Finance

Quest Diagnostics reports strong performance in third quarter 2006 on 16% revenue growth

Published in Law and Health Weekly, November 18th, 2006

Quest Diagnostics Incorporated (DGX) announced that for the third quarter income from continuing operations was $164 million, or $0.82 per diluted share compared to $140 million, or $0.68 per diluted share for the prior year.

Net income for 2006 was reduced by $13 million of pretax expenses, or $0.04 per share, associated with stock-based compensation recorded in accordance with SFAS 123R.

Third quarter revenues from continuing operations grew 16.3% over the prior year level to $1.6 billion. The acquisition of LabOne, which was completed on November 1, 2005, increased revenues by 9.4%, and the acquisition of Focus Diagnostics, which was completed on...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2006-11-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry